Commentary on “Shifting Paradigm: Utilization and Outcomes with Neoadjuvant Chemotherapy for cT4 and cN2 Colon Cancers”

Key Points

• This commentary evaluates the shifting paradigm in the use of neoadjuvant chemotherapy for advanced colon cancers.
• Analysis of existing literature on neoadjuvant chemotherapy utilization for cT4 and cN2 colon cancers.
• Evaluation of treatment outcomes and survival rates associated with neoadjuvant chemotherapy.
• Emerging evidence suggests improved outcomes with neoadjuvant chemotherapy in cT4 and cN2 cases.
• Variability in utilization patterns indicates a need for standardized treatment protocols.

Abstract